Study of Hypercortisolism in Cushing's Syndrome and Stress-Induced Pseudo-Cushing's Syndrome
NCT00004343 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2005-06-24
Summary
OBJECTIVES:
I. Determine whether Cushing's syndrome and stress-induced pseudo-Cushing's syndrome can be differentiated by evaluating endogenous corticotropin-releasing hormone activity.
Conditions
Sponsors & Collaborators
-
Oregon Health and Science University
collaborator OTHER -
National Center for Research Resources (NCRR)
lead NIH
Principal Investigators
-
Mary H. Samuels · Oregon Health and Science University
Eligibility
- Min Age
- 0 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1999-10-31
Countries
- United States
Study Locations
More Related Trials
-
Insulin Sensitivity and Substrate Metabolism in Patients With Cushing's Syndrome
NCT00682084 ·Status: TERMINATED
-
The Accuracy of Late Night Urinary Free Cortisol/Creatinine and Hair Cortisol in Cushing's Syndrome Diagnosis
NCT02791698 ·Status: UNKNOWN
-
Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly
NCT00004332 ·Status: COMPLETED
-
Alterations of Muscle Secretome Associated With Muscle Atrophy Caused by Glucocorticoids
NCT03229395 ·Status: COMPLETED
-
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
NCT00422201 ·Status: TERMINATED ·Phase: PHASE2
-
The Factors Associated With the Recurrence in Patients With Cushing Disease
NCT02233335 ·Status: COMPLETED
-
Treatment for Endogenous Cushing's Syndrome
NCT01838551 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome
NCT02019706 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing s Disease
NCT04339751 ·Status: WITHDRAWN ·Phase: PHASE2
-
Genomic and Metabolomic Markers Reflecting the Complications of Hypercortisolism (CUSHINGOMICS)
NCT04840693 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Hair Cortisol and Cushing's Disease
NCT04201444 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors
NCT07335315 ·Status: RECRUITING
-
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
NCT03604198 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Metabolic Effects of Acute Cortisol Withdrawal in Adrenal Failure
NCT00442390 ·Status: COMPLETED ·Phase: NA
-
A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement
NCT06430528 ·Status: RECRUITING
-
The Hypothalamic-Pituitary-Adrenal (HPA) Axis as an Effector System in Weight Regulation
NCT00688987 ·Status: COMPLETED ·Phase: NA
-
Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome
NCT05382156 ·Status: ACTIVE_NOT_RECRUITING
-
The Risk of Adrenal Insufficiency and Cushing Syndrome Associated With Glucocorticoid Therapy in People With Chronic Inflammatory Diseases
NCT03575247 ·Status: COMPLETED
-
Long-Term Follow-Up of Survivors of Pediatric Cushing Disease
NCT03831958 ·Status: RECRUITING
-
Effects of Hormone Stimulation on Brain Scans for Cushing s Disease
NCT01459237 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Updated Diagnostic Cortisol Values for Adrenal Insufficiency
NCT05149638 ·Status: RECRUITING ·Phase: NA
-
Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome
NCT02468193 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
NCT02922257 ·Status: COMPLETED
-
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
NCT05804669 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Cortisol Response to Adrenocorticotrophin (ACTH) in Acute Stress
NCT00493389 ·Status: UNKNOWN ·Phase: NA